Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SOX12 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Sox12 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SOX12 mRNA | CTD | PMID:36331819 | SOX12 | Human | 1,2-dichloroethane | increases expression | ISO | Sox12 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of SOX12 mRNA | CTD | PMID:28189721 and PMID:28960355 | SOX12 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sox12 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SOX12 mRNA | CTD | PMID:21570461 | SOX12 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SOX12 mRNA | CTD | PMID:33387578 | SOX12 | Human | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Sox12 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of SOX12 mRNA | CTD | PMID:25172293 | SOX12 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SOX12 mRNA | CTD | PMID:23724009 | SOX12 | Human | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of SOX12 mRNA | CTD | PMID:22378314 | SOX12 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of SOX12 exon | CTD | PMID:27901495 | SOX12 | Human | bisphenol A | decreases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SOX12 mRNA | CTD | PMID:25181051 | SOX12 | Human | bisphenol A | increases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SOX12 mRNA | CTD | PMID:30816183 | SOX12 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of SOX12 mRNA | CTD | PMID:26079696 | SOX12 | Human | cadmium dichloride | decreases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of SOX12 mRNA | CTD | PMID:33453195 | SOX12 | Human | camptothecin | increases methylation | EXP | | 6480464 | Camptothecin results in increased methylation of SOX12 gene | CTD | PMID:30720231 | SOX12 | Human | chlorpyrifos | increases expression | ISO | Sox12 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SOX12 mRNA | CTD | PMID:37019170 | SOX12 | Human | choline | multiple interactions | ISO | Sox12 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOX12 gene | CTD | PMID:20938992 | SOX12 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of SOX12 mRNA | CTD | PMID:27594783 | SOX12 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SOX12 mRNA | CTD | PMID:27392435 | SOX12 | Human | cobalt dichloride | decreases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of SOX12 mRNA | CTD | PMID:24386269 | SOX12 | Human | copper atom | multiple interactions | ISO | Sox12 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of SOX12 mRNA | CTD | PMID:26033743 | SOX12 | Human | copper(0) | multiple interactions | ISO | Sox12 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of SOX12 mRNA | CTD | PMID:26033743 | SOX12 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SOX12 mRNA | CTD | PMID:19549813 | SOX12 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of SOX12 mRNA | CTD | PMID:25562108 | SOX12 | Human | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of SOX12 gene | CTD | PMID:22964155 | SOX12 | Human | dibutyl phthalate | decreases expression | ISO | Sox12 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of SOX12 mRNA | CTD | PMID:21266533 | SOX12 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of SOX12 mRNA | CTD | PMID:28302478 | SOX12 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX12 mRNA | CTD | PMID:27188386 | SOX12 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SOX12 mRNA | CTD | PMID:29803840 | SOX12 | Human | ethanol | affects splicing | ISO | Sox12 (Mus musculus) | 6480464 | Ethanol affects the splicing of SOX12 mRNA | CTD | PMID:30319688 | SOX12 | Human | folic acid | multiple interactions | ISO | Sox12 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOX12 gene | CTD | PMID:20938992 | SOX12 | Human | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of SOX12 mRNA | CTD | PMID:21867686 | SOX12 | Human | gentamycin | decreases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SOX12 mRNA | CTD | PMID:33387578 | SOX12 | Human | L-methionine | multiple interactions | ISO | Sox12 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOX12 gene | CTD | PMID:20938992 | SOX12 | Human | maneb | multiple interactions | ISO | Sox12 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of SOX12 mRNA | CTD | PMID:36117858 | SOX12 | Human | paracetamol | decreases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of SOX12 mRNA | CTD | PMID:33387578 | SOX12 | Human | paraquat | multiple interactions | ISO | Sox12 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of SOX12 mRNA | CTD | PMID:36117858 | SOX12 | Human | PCB138 | decreases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:23829299 | SOX12 | Human | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of SOX12 mRNA | CTD | PMID:26079696 | SOX12 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Sox12 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SOX12 mRNA | CTD | PMID:36331819 | SOX12 | Human | propanal | decreases expression | EXP | | 6480464 | propionaldehyde results in decreased expression of SOX12 mRNA | CTD | PMID:26079696 | SOX12 | Human | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SOX12 mRNA | CTD | PMID:29955902 | SOX12 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX12 mRNA | CTD | PMID:27188386 | SOX12 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of SOX12 mRNA | CTD | PMID:25351596 | SOX12 | Human | Soman | increases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | Soman results in increased expression of SOX12 mRNA | CTD | PMID:19281266 | SOX12 | Human | trichloroethene | decreases expression | ISO | Sox12 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of SOX12 mRNA | CTD | PMID:33387578 | SOX12 | Human | Triptolide | decreases expression | ISO | Sox12 (Mus musculus) | 6480464 | triptolide results in decreased expression of SOX12 mRNA | CTD | PMID:32835833 | SOX12 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of SOX12 mRNA | CTD | PMID:28818685 | SOX12 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SOX12 mRNA | CTD | PMID:23179753 more ... | SOX12 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX12 mRNA | CTD | PMID:27188386 | SOX12 | Human | zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of SOX12 mRNA | CTD | PMID:19071009 | SOX12 | Human | zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of SOX12 mRNA | CTD | PMID:19071009 | |